CULLEN/FROST BANKERS, INC. – Alnylam Pharmaceuticals, Inc. Transaction History
CULLEN/FROST BANKERS, INC. portfolio value:
$2.11M
portfolio value
CULLEN/FROST BANKERS, INC. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.65% | -400 shares | 514K | $200.16 | 10.54K |
| Q2 2022 | share | 0.00% | 0 shares | -191K | $145.85 | 10.94K | |
| Q1 2022 | share | Increase | +3.79% | 400 shares | -1K | $163.29 | 10.94K |
| Q4 2021 | share | 0.00% | 0 shares | -203K | $171.03 | 10.54K | |
| Q3 2021 | share | 0.00% | 0 shares | 204K | $188.81 | 10.54K | |
| Q2 2021 | share | Decrease | -10.03% | -1.17K shares | 133K | $169.52 | 10.54K |
| Q1 2021 | share | 0.00% | 0 shares | 131K | $141.19 | 11.72K | |
| Q4 2020 | share | Decrease | -41.40% | -8.28K shares | -1.38M | $129.97 | 11.72K |
| Q3 2020 | share | Decrease | -4.03% | -840 shares | -175K | $145.6 | 20.00K |
| Q2 2020 | share | Decrease | -7.43% | -1.67K shares | 636K | $148.11 | 20.84K |
| Q1 2020 | share | Increase | 0.00% | 22.52K shares | 2.45M | $108.85 | 22.52K |